Literature DB >> 1936271

PDGF suppresses the activation of group II phospholipase A2 gene expression by interleukin 1 and forskolin in mesangial cells.

H Mühl1, T Geiger, W Pignat, F Märki, H van den Bosch, K Vosbeck, J Pfeilschifter.   

Abstract

Treatment of rat mesangial cells with interleukin 1 beta (IL-1 beta) and forskolin greatly enhanced the expression of group II phospholipase A2 (PLA2) mRNA, with subsequent increased synthesis and secretion of PLA2, as detected by PLA2 activity measurements and immunoprecipitation of culture media of [35S]methionine-labelled mesangial cells. PDGF-BB dose-dependently suppressed the IL-1 beta- and forskolin-induced elevation of PLA2 mRNA, as well as PLA2 synthesis and secretion. In contrast, PDGF-AA had no inhibitory effect. The tyrosine kinase inhibitor genistein dose-dependently antagonized the inhibitory effect of PDGF-BB on IL-1 beta-stimulated PLA2 secretion, thus suggesting that tyrosine phosphorylation may be required for PDGF-BB inhibition of PLA2 gene expression in mesangial cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936271     DOI: 10.1016/0014-5793(91)81295-j

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Down-regulation by prostaglandins of type-II phospholipase A2 expression in guinea-pig alveolar macrophages: a possible involvement of cAMP.

Authors:  D Vial; L Arbibe; N Havet; C Dumarey; B Vargaftig; L Touqui
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

2.  Posttranscriptional effect of insulin-like growth factor-I on interleukin-1beta-induced type II-secreted phospholipase A2 gene expression in rabbit articular chondrocytes.

Authors:  C Jacques; G Béréziat; L Humbert; J L Olivier; M T Corvol; J Masliah; F Berenbaum
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

3.  Phospholipase A2 is secreted by murine keratinocytes after stimulation with IL-1 alpha and TNF-alpha.

Authors:  B C Bastian; R J Schacht; E Kämpgen; E B Bröcker
Journal:  Arch Dermatol Res       Date:  1996-03       Impact factor: 3.017

Review 4.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

5.  Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells.

Authors:  J Pfeilschifter; C Schalkwijk; V A Briner; H van den Bosch
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

Review 6.  The inflammatory function of renal glomerular mesangial cells and their interaction with the cellular immune system.

Authors:  H H Radeke; K Resch
Journal:  Clin Investig       Date:  1992-09

7.  Cytokine regulation of group II phospholipase A2 expression in glomerular mesangial cells.

Authors:  J Pfeilschifter; H Mühl; W Pignat; F Märki; H van den Bosch
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Modulatory role of platelet-derived growth factor on cytokine-induced nerve growth factor synthesis in rat glomerular mesangial cells.

Authors:  K M Plüss; J Pfeilschifter; H Mühl; A Huwiler; C Boeckh; U Otten
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

9.  Epidermal growth factor and phorbol myristate acetate increase expression of the mRNA for cytosolic phospholipase A2 in glomerular mesangial cells.

Authors:  A P Maxwell; H J Goldberg; A H Tay; Z G Li; G S Arbus; K L Skorecki
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

10.  Effects of dexamethasone and transforming growth factor-beta 2 on group II phospholipase A2 mRNA and activity levels in interleukin 1 beta- and forskolin-stimulated mesangial cells.

Authors:  M J Vervoordeldonk; C G Schalkwijk; J Pfeilschifter; H van den Bosch
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.